Frontlight ResearchEarly access
Trial site
Oncology Hematology West P.C. dba Nebraska Cancer Specialists
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer2 trials
- Melanoma2 trials
- Acute lymphoblastic leukaemia1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- and 3 more
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Pfizer2 trials
- Regeneron Pharmaceuticals2 trials
- AVM Biotechnology Inc1 trial
- BioNTech SE1 trial
- Bristol-Myers Squibb1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
Closed trials
Completed
Completed
Completed
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
Site data: ClinicalTrials.govUpdated 14 Nov 2026